RxSight, Inc. Pay versus Performance
The Pay versus Performance table from each proxy statement (Item 402(v)), as tagged in its XBRL, newest proxy first. Each proxy's own figures are kept, so a year restated in a later proxy appears once per proxy. PEO is the principal executive officer; NEO means the other named executive officers (average). Total shareholder return is the value of a $100 investment.
- 2025-12-31: PEO total compensation $4.65M; PEO compensation actually paid -$2.16M; Other NEO average total compensation $2.48M.
- 2024-12-31: PEO total compensation $6.98M; PEO compensation actually paid $5.12M; Other NEO average total compensation $5.80M.
- 2023-12-31: PEO total compensation $3.08M; PEO compensation actually paid $11.80M; Other NEO average total compensation $1.81M.
- 2022-12-31: PEO total compensation $1.03M; PEO compensation actually paid $1.25M; Other NEO average total compensation $649.36K.
| Fiscal year end | PEO | PEO total compensation | PEO compensation actually paid | Other NEO average total compensation | Other NEO average compensation actually paid | Total shareholder return | Peer group total shareholder return | Net income | Company-selected measure | Proxy filed |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | $4.65M | -$2.16M | $2.48M | -$1.33M | $92.62 | $76.03 | -$38.90 | Revenue $134.50M | 2026-04-28 | |
| 2024-12-31 | $6.98M | $5.12M | $5.80M | $4.22M | $305.60 | $76.22 | -$27.50 | $139.90M | 2026-04-28 | |
| 2023-12-31 | $3.08M | $11.80M | $1.81M | $6.26M | $358.40 | $72.30 | -$48.60 | $89.10M | 2026-04-28 | |
| 2022-12-31 | $1.03M | $1.25M | $649.36K | $762.52K | $112.62 | $76.64 | -$66.80 | $49.00M | 2026-04-28 | |
| 2024-12-31 | $6.98M | $5.12M | $5.80M | $4.22M | $305.60 | $76.22 | -$27.50 | revenue $139.90M | 2025-04-21 | |
| 2023-12-31 | $3.08M | $11.80M | $1.81M | $6.26M | $358.40 | $72.30 | -$48.60 | $89.10M | 2025-04-21 | |
| 2022-12-31 | $1.03M | $1.25M | $649.36K | $762.52K | $112.62 | $76.64 | -$66.80 | $49.00M | 2025-04-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Innovative Eyewear Inc (LUCY) | United States | $0.008B | |
| STAAR SURGICAL CO (STAA) | United States | $0.957B | 362.70 |
| National Vision Holdings, Inc. (EYE) | United States | $1.297B | |
| Warby Parker Inc. (WRBY) | United States | $2.970B | |
| Bausch & Lomb Corp (BLCO) | Canada | $6.008B | -34.58 |
| COOPER COMPANIES, INC. (COO) | United States | $10.533B | 24.09 |